| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264944 Mechanically elongated neuronal cells |
| 07/24/2001 | US6264943 Parkinson's disease |
| 07/24/2001 | CA2205006C Modified green fluorescent proteins |
| 07/24/2001 | CA2040810C Process for producing foreign proteins in streptomyces |
| 07/19/2001 | WO2001051922A2 Identification of peripheral benzodiazepine receptor binding agents |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051644A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN Cν3 AND Cν4 DOMAINS |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051641A1 Irak-4: compositions and methods of use |
| 07/19/2001 | WO2001051638A2 Drug metabolizing enzymes |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051623A1 Cod uracil-dna glycosylase, gene coding therefore, recombinant dna containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling pcr |
| 07/19/2001 | WO2001051619A2 Genetically modified fibroblast cell |
| 07/19/2001 | WO2001051618A2 Purification of microglial cells |
| 07/19/2001 | WO2001051617A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | WO2001051616A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 07/19/2001 | WO2001051615A1 Method for increasing survival rate of cells in animal cell culture under hypoxia condition |
| 07/19/2001 | WO2001051614A1 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition |
| 07/19/2001 | WO2001051613A1 Method for inhibiting apoptosis under ischemic condition |
| 07/19/2001 | WO2001051612A1 Process for the production of non-human embryos of high-genetic value and of predetermined sex |
| 07/19/2001 | WO2001051611A1 Cell production |
| 07/19/2001 | WO2001051610A1 Ectoderm cell production |
| 07/19/2001 | WO2001051609A1 Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons |
| 07/19/2001 | WO2001051608A2 Hybrid cells obtainable from antigen presenting cells |
| 07/19/2001 | WO2001051606A2 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | WO2001051602A1 Method and apparatus for tissue treatment |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051462A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 07/19/2001 | WO2001051093A2 METHODS OF INCREASING THE GLUCOSE RESPONSIVENESS OF PANCREATIC β-CELLS |
| 07/19/2001 | WO2001051069A1 Use of dictyotal extracts in the production of a topical composition |
| 07/19/2001 | WO2001051006A2 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | WO2001050851A2 Storage of cells, tissues and organs in gel-based media |
| 07/19/2001 | WO2001050848A2 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001009302A3 Agrobacterium-mediated plant transformation method |
| 07/19/2001 | WO2001007585A8 Electrical impedance tomography to control electroporation |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005941A3 Storage of microorganisms, cells and tissue |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000078814A3 LO-CD2b ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 07/19/2001 | WO2000078813A3 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
| 07/19/2001 | WO2000073431B1 Methods and compositions for measuring ion channel conductance |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000046351A3 Platform for the differentiation of cells |
| 07/19/2001 | WO2000025808A9 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 07/19/2001 | WO2000023573A9 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010009040 Introducing expression cassette comprising coding for fumonisin esterase enzyme and identifying transformed/ surviving plant cells |
| 07/19/2001 | US20010008772 Lipid, nucleic acid complex |
| 07/19/2001 | DE10001390A1 Zelllinie zur Herstellung und Produktion von Schafadenovirusvektoren Cell line for the manufacture and production of Schafadenovirusvektoren |
| 07/19/2001 | CA2823768A1 Hybrid cells |
| 07/19/2001 | CA2406901A1 Identification of peripheral benzodiazepine receptor binding agents |
| 07/19/2001 | CA2406722A1 Dna modification proteins |
| 07/19/2001 | CA2397741A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | CA2397481A1 Irak-4: compositions and methods of use |
| 07/19/2001 | CA2397340A1 Drug metabolizing enzymes |
| 07/19/2001 | CA2397334A1 Secreted proteins |
| 07/19/2001 | CA2397292A1 Cell production |
| 07/19/2001 | CA2397207A1 Novel stra6 polypeptides |
| 07/19/2001 | CA2397199A1 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | CA2397053A1 Human and parasite orphan receptor proteins |
| 07/19/2001 | CA2397003A1 Cell line for preparing and producing ovine adenovirus vectors |
| 07/19/2001 | CA2396996A1 Genetically modified fibroblast cell |
| 07/19/2001 | CA2396348A1 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | CA2396247A1 Clonal propagation of primate offspring by embryo splitting |
| 07/19/2001 | CA2395975A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 07/19/2001 | CA2394831A1 Monocyte-derived dendritic cell subsets |
| 07/19/2001 | CA2391467A1 Method and apparatus for tissue treatment |
| 07/18/2001 | EP1116794A2 Transgenic plants carrying neoxanthin cleavage enzyme gene |
| 07/18/2001 | EP1116793A1 Homeobox genes encoding proteins participating in differentiation |
| 07/18/2001 | EP1116792A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 07/18/2001 | EP1116032A1 Gpr10 as a target for identifying weight modulating compounds |
| 07/18/2001 | EP1116028A1 Ndp |
| 07/18/2001 | EP1115879A1 Retroviral particles protected against complement mediated destruction |
| 07/18/2001 | EP1115877A1 Polynucleotide constructs and uses thereof |
| 07/18/2001 | EP1115876A2 Receptor based antagonists and methods of making and using |
| 07/18/2001 | EP1115875A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae |
| 07/18/2001 | EP1115874A2 Alzheimer's disease secretase |
| 07/18/2001 | EP1115868A2 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/18/2001 | EP1115867A1 Human interleukin-b50. therapeutic uses |
| 07/18/2001 | EP1115865A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 07/18/2001 | EP1115864A2 Human chaperone proteins |
| 07/18/2001 | EP1115863A1 Ucp4 |
| 07/18/2001 | EP1115862A2 Cytokine receptor zalpha11 |
| 07/18/2001 | EP1115860A2 Membrane-associated organizational proteins |
| 07/18/2001 | EP1115859A2 Hairpin hybridizer molecules for modulation of gene expression |
| 07/18/2001 | EP1115857A1 Use of specific hybrid promoters for controlling tissue expression |